Abbott Laboratories (ABT) Declares Quarterly Dividend of $0.14
Abbott Laboratories (NYSE:ABT) declared a quarterly dividend on Thursday, September 12th, ARN reports. Shareholders of record on Tuesday, October 15th will be given a dividend of $0.14 per share on Friday, November 15th. This represents a $0.56 dividend on an annualized basis and a yield of 1.61%.
Several analysts have recently commented on the stock. Analysts at Jefferies Group reiterated a “buy” rating on shares of Abbott Laboratories (NYSE:ABT) in a research note to investors on Wednesday, September 4th. They now have a $44.00 price target on the stock, down previously from $46.00. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Abbott Laboratories (NYSE:ABT) in a research note to investors on Friday, August 30th. They now have a $35.00 price target on the stock.
One analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $38.14.
Abbott Laboratories (NYSE:ABT) traded up 0.07% during mid-day trading on Thursday, hitting $34.775. 5,445,176 shares of the company’s stock traded hands. Abbott Laboratories has a one year low of $29.9761 and a one year high of $38.77. The stock has a 50-day moving average of $35.1 and a 200-day moving average of $35.72. The company has a market cap of $54.045 billion and a price-to-earnings ratio of 13.86.
Abbott Laboratories (NYSE:ABT) last issued its quarterly earnings data on Wednesday, July 17th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.44 by $0.02. The company had revenue of $5.45 billion for the quarter, compared to the consensus estimate of $5.53 billion. During the same quarter in the prior year, the company posted $1.23 earnings per share. The company’s quarterly revenue was up 2.5% on a year-over-year basis. Analysts expect that Abbott Laboratories will post $2.01 EPS for the current fiscal year.
Abbott Laboratories (NYSE:ABT), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.